Lamin B1 safeguards the B cell genome and shapes lymphoma outcome
HemaSphere · 2026-06 · 10 (6)
DOI: 10.1002/hem3.70387 ↗Kurz gefasst
Fachartikel in der Zeitschrift HemaSphere, online erschienen am 07.06.2026. Verfasst von Filip Filipsky und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, 3rd Floor John Vane Science Centre, Charterhouse Square London …. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Blood Cancer UK.
Abstract (Originalsprache)
Lamin B1 is a structural component of the nuclear lamina that participates in genome organization and transcriptional control. During adaptive immune responses, B lymphocytes in germinal centers (GCs) undergo clonal expansion and programmed DNA damage at immunoglobulin loci, while simultaneously downregulating Lamin B1. Likewise, Lamin B1 downregulation has been observed in GC‐derived lymphomas and myeloid malignancies, yet the functional consequences of Lamin B1 loss during B cell development remain poorly understood. Here, we used in vivo and in vitro B cell models of conditional hypomorphic Lamin B1 expression, which showed elevated DNA damage and disrupted transcriptional profiles. Using sBLISS (in situ labeling and sequencing of double‐strand breaks), we identified nonrandom double‐strand break hotspots in both mouse and human GC B cells depleted of Lamin B1. These breaks are preferentially located near transcriptional start sites (TSSs) and regulatory elements that control translation and mRNA fate, suggesting Lamin B1 has a role in protecting regulatory genomic regions. Moreover, low LMNB1 expression is associated with poor clinical outcomes in patients with diffuse large B‐cell lymphoma (DLBCL). Together, this study reveals a crucial role for Lamin B1 in preserving genomic stability in B cells, underscoring its impact on the pathogenesis of B cell‐derived malignancies.
Autor:innen und Institutionen
- Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, 3rd Floor John Vane Science Centre, Charterhouse Square London UK.
- Department of Biomedicine University Hospital and University of Basel Basel Switzerland.
- Kirchhoff-Institute for Physics, Heidelberg University, Heidelberg Germany.
- Present address: Department of Optical Nanoscopy Max Planck Institute for Medical Research Heidelberg 69120 Germany.
- Centre for Cancer Immunology, Faculty of Medicine University of Southampton Southampton UK.
- Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London London UK.
ORCID-Profile: Marta C Sallan
Förderung
- Blood Cancer UK
Zitieren
APA
Filipsky, F., Chapman, K. B., Bloehdorn, J., Maiques, O., Lee, A., Clear, A., Wang, J., Gribben, J., Hausmann, M., Cremer, C., Braun, A., Sallan, M. C., & Klymenko, T. (2026). Lamin B1 safeguards the B cell genome and shapes lymphoma outcome. HemaSphere, 10(6). https://doi.org/10.1002/hem3.70387
Vancouver
Filipsky F, Chapman KB, Bloehdorn J, Maiques O, Lee A, Clear A, et al. Lamin B1 safeguards the B cell genome and shapes lymphoma outcome. HemaSphere. 2026;10(6). doi:10.1002/hem3.70387
BibTeX
@article{Filipsky2026,
author = {Filipsky, Filip and Chapman, Katarina B and Bloehdorn, Johannes and Maiques, Oscar and Lee, Abigail and Clear, Andrew and Wang, Jun and Gribben, John and Hausmann, Michael and Cremer, Christoph and Braun, Andrejs and Sallan, Marta C and Klymenko, Tanya},
title = {Lamin B1 safeguards the B cell genome and shapes lymphoma outcome},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {6},
doi = {10.1002/hem3.70387}
}
EUVIMED